Coronary Artery Disease Clinical Trials in Cleveland, Ohio

14 studies are recruiting for coronary artery disease in Cleveland, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Product Surveillance Registry

    The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by str…

    Stage
    Not phased
    Ages
    Any age
    Site
    Research site, Cleveland, Ohio
    Locations
    401 in total
    Run by
    Medtronic

    See if you can join NCT01524276 on ClinicalTrials.gov

  2. Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

    This is a two-part study, comprised of an initial open-label run-in phase (Part 1) in a subset of 3 subjects to provide first data regarding safety, and feasibility of the percutaneous endovascular catheter-facilitated intramyocardial delivery of XC001 in patients with RA due to obstructive CAD. Pa…

    Stage
    Phase 2
    Ages
    18 to 85
    Site
    Cleveland Clinic, Cleveland, Ohio
    Locations
    14 in total
    Run by
    XyloCor Therapeutics, Inc.

    See if you can join NCT07048808 on ClinicalTrials.gov

  3. Randomization of Single vs Multiple Arterial Grafts

    The primary hypothesis of ROMA is that in patients undergoing primary isolated non-emergent coronary artery bypass surgery (CABG), the use of two or more arterial grafts compared to a single arterial graft is associated with a reduction in the composite outcome of death from any cause, any stroke, …

    Stage
    Not phased
    Ages
    18 to 70
    Site
    Cleveland Clinic Foundation, Cleveland, Ohio
    Locations
    59 in total
    Run by
    Weill Medical College of Cornell University

    See if you can join NCT03217006 on ClinicalTrials.gov

  4. Prospective Global Registry for the Study of Chronic Total Occlusion Intervention

    Percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is increasingly being performed in patients with advanced coronary artery disease, but there is limited information on the techniques utilized and the procedural outcomes. The goal of this multicenter, investigator initiate…

    Stage
    Not phased
    Ages
    Any age
    Site
    University Hospitals (UH) Case Western Reserve University, Cleveland, Ohio
    Locations
    48 in total
    Run by
    Minneapolis Heart Institute Foundation

    See if you can join NCT02061436 on ClinicalTrials.gov

  5. SELUTION 4 De Novo Small Vessel IDE Trial

    Prospective, randomized controlled, single-blind, multicenter, clinical trial to demonstrate the safety and efficacy of the SELUTION SLR 014 PTCA DEB for treatment of de novo lesions in small coronary vessels, defined as reference vessel diameter (RVD) of 2.00 mm to 2.75 mm, in support of a pre-mar…

    Stage
    Not phased
    Ages
    18 and older
    Site
    UH Cleveland, Cleveland, Ohio
    Locations
    70 in total
    Run by
    M.A. Med Alliance S.A.

    See if you can join NCT05946629 on ClinicalTrials.gov

  6. ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)

    The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.

    Stage
    Not phased
    Ages
    18 and older
    Site
    University Hospitals Cleveland Medical Center, Cleveland, Ohio
    Locations
    19 in total
    Run by
    Emory University

    See if you can join NCT07559903 on ClinicalTrials.gov

  7. CTSN Embolic Protection Trial

    This is a prospective, multi-center, randomized effectiveness trial of the CardioGard Embolic Protection Cannula in high-risk valve surgery patients.

    Stage
    Not phased
    Ages
    60 and older
    Site
    Cleveland Clinic, Cleveland, Ohio
    Locations
    28 in total
    Run by
    Icahn School of Medicine at Mount Sinai

    See if you can join NCT06027788 on ClinicalTrials.gov

  8. The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)

    The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy (STICH3C) trial is a prospective, unblinded, international multi-center randomized trial of 754 subjects enrolled in approximately 45 centers comparing revascularization by percutaneous coronary intervention (PCI) vs. coronary artery…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University Hospitals Cleveland Medical Center, Cleveland, Ohio
    Locations
    43 in total
    Run by
    Sunnybrook Health Sciences Centre

    See if you can join NCT05427370 on ClinicalTrials.gov

  9. Prevail Global Study

    The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.

    Stage
    Not phased
    Ages
    18 and older
    Site
    University Hospitals Cleveland Medical Center, Cleveland, Ohio
    Locations
    51 in total
    Run by
    Medtronic Vascular

    See if you can join NCT06535854 on ClinicalTrials.gov

  10. The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial

    Heart disease remains the leading cause of death in Veterans. Inflammation in the arteries of the heart may increase the risk of cardiac death. Patients with heart disease undergoing major surgery are at increased risk of complications after surgery, including heart attack, stroke, and death. The p…

    Stage
    Phase 4
    Ages
    18 and older
    Site
    Louis Stokes VA Medical Center, Cleveland, OH, Cleveland, Ohio
    Locations
    9 in total
    Run by
    VA Office of Research and Development

    See if you can join NCT05618353 on ClinicalTrials.gov

  11. Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

    The central hypothesis of ROMA:Women is that the use of multiple arterial grafting (MAG) will improve clinical outcomes and quality of life (QOL) compared to single arterial grafting (SAG). The specific aims of ROMA:Women are: Aim 1: Determine the impact of MAG vs SAG on major adverse cardiac and c…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Cleveland Clinic Foundation, Cleveland, Ohio
    Locations
    146 in total
    Run by
    Weill Medical College of Cornell University

    See if you can join NCT04124120 on ClinicalTrials.gov

  12. MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

    This is a multicenter, randomized, single-blind pivotal study to evaluate the safety and efficacy of the MagicTouchTM Drug coated balloon in treatment of small vessels in patients with coronary artery disease. The objective is to establish the safety and efficacy of the Magic TouchTM Drug coated ba…

    Stage
    Not phased
    Ages
    18 to 80
    Site
    University Hospitals, Cleveland Medical Center, Cleveland, Ohio
    Locations
    24 in total
    Run by
    Concept Medical Inc.

    See if you can join NCT06271590 on ClinicalTrials.gov

  13. Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

    COMPLETE-2 is a prospective, multi-centre, randomized controlled trial comparing a strategy of physiology-guided complete revascularization to angiography-guided complete revascularization in patients with acute ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardi…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Cleveland Clinic, Cleveland, Ohio
    Locations
    113 in total
    Run by
    Population Health Research Institute

    See if you can join NCT05701358 on ClinicalTrials.gov

  14. MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

    A Prospective, Multicenter, Randomized, Two-Arm, Single-blind Superiority Trial to Evaluate the Safety and Efficacy of the MagicTouch™ Sirolimus- Coated Balloon in the Treatment of Coronary Drug-Eluting Stent In-Stent Restenosis. Subjects with prior DES implantation presenting with ISR lesions unde…

    Stage
    Not phased
    Ages
    18 to 110
    Site
    Cleveland Clinic, Cleveland, Ohio
    Locations
    28 in total
    Run by
    Concept Medical Inc.

    See if you can join NCT05908331 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.